The combination offers a potential solution to one of the key problems that’s emerged with popular obesity shots.

Find insight on Novo Nordisk, Bumrungrad Hospital, Riverstone Holdings, and more in the latest Market Talks covering Health ...

Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments ...

Key Takeaways Hims & Hers shares plunged 30% in intraday trading Monday after Novo Nordisk said it is pulling Wegovy from the ...

Shares in Novo Nordisk fell as much as 3.5 per cent on Monday after detailed trial data on its experimental obesity drug ...